Big Pharma leads the charge in TV ad spending increases, analyst report finds
03 June 2016
And the spend goes on. The latest pharma ad news is from Morgan Stanley, which notes pharma companies are leading the way in a national TV spending upswing.
Competition watchdog details vaccine market concerns
03 June 2016
Where some see a small cadre of top-notch vaccine companies, others might see an oligopoly. Where some see innovation, others see hard-to-copy jabs that keep generics away and prices high.
02 June 2016
Atlas Genetics Ltd (“Atlas Genetics” or the “Company”), the STI Point-Of-Care (POC) molecular diagnostics company, today notes the major issue of antibiotic resistance for Sexually Transmitted Infections (STIs), as highlighted in the UK Government commissioned anti-microbial resistance report, chaired by Jim O’Neill – ‘Tackling Drug-Resistant Infections Globally’ and recently referenced on the BBC program Newsnight. The O’Neill report recommends that in high income countries health system leaders should ‘support the uptake and use of rapid point-of care diagnostics in primary and secondary care.
How can patients get their money's worth from cancer meds?
02 June 2016
The American Society of Clinical Oncology stepped up the drug-cost debate last year when it proposed a tool to help doctors and patients compare potential treatments. Now, after collecting critiques from providers, patients and the pharma industry, the influential organization has rolled out a new version of that “value framework.”
India plans drug industry foreign investment scorecard
02 June 2016
India's Commerce and Industry Ministry plans to measure the impact of foreign investment on the drug industry in a step that will be closely watched for any conclusions for--or against--more activity in the sector.
White House posts data security framework for Precision Medicine
02 June 2016
The White House has released a data security framework to help organizations participating in the Precision Medicine Initiative (PMI) protect information on individuals. Officials have opted against taking a prescriptive approach and have instead tried to create a framework that organizations can adapt to their specific needs and responsibilities.
China to probe drug, device pricing among domestic, foreign firms
02 June 2016
China's National Development and Reform Commission (NDRC) will launch an investigation into all aspects of drug and medical device sales and prices among domestic and foreign firms in a step that could lead to enforcement action.
Clearside Biomedical, Inc. Announces Pricing of Initial Public Offering
01 June 2016
Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the pricing of its initial public offering of 7,200,000 shares of its common stock at a public offering price of $7.00 per share.
China FDA logs more than 320,000 device adverse medical reports in 2015
01 June 2016
China FDA has released an updated tally of adverse event reporting for medical devices that found more than 320,000 incidents were noted in 2015 with 80% from users of medical equipment. A separate report linked 184 deaths to incidents involving devices.
New medicines targeting age-related macular degeneration
01 June 2016
Significant progress has been made in ophthalmology, with biopharma companies working on innovative treatments for sight-threatening diseases. As the research accelerates, promising gene therapy, stem cell-based and biopharmaceutical product candidates have progressed into clinical trials. Those innovative next-generation therapies will be welcomed as millions of people around the world suffer from blinding retinal degenerative diseases.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russia has expanded the mandatory health insurance program for 2024-2026
29 March 2024
Russian scientists have developed new TB vaccines for both injection and nasal administration.
29 March 2024
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024